Fund Holdings — Blue Owl Capital Holdings LP

Total Portfolio Value:
$658.00M
Total Bought:
$342.03M
Total Sold:
$126.46M
Net Transaction:
+$215.57M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
SPACE EXPLORATION TECHN CORP01,398,815+1,398,815$0$239.00M36.32%+$239.00M
Aktis Oncology, Inc.(AKTS)3,161,3483,070,219-91,129$56.56M$98.95M15.04%+$42.40M
Cullinan Therapeutics, Inc.(CGEM)1,909,7641,539,764-370,000$27.14M$28.04M4.26%+$901.4K
LARIMAR THERAPEUTICS INC7,120,0079,163,157+2,043,150$32.04M$27.95M4.25%-$4.09M
NUVEEN CHURCHILL DIRECT LEND2,143,6262,143,6260$27.27M$26.62M4.05%-$643.1K
MAPLIGHT THERAPEUTICS INC1,005,929729,929-276,000$20.45M$26.16M3.98%+$5.71M
Capital One Financial Corporation(COF)0119,757+119,757$0$24.03M3.65%+$24.03M
Blue Owl Capital Corporation(OBDC)2,045,0702,045,0700$22.62M$22.23M3.38%-$388.6K
DEEP FISSION INC01,333,333+1,333,333$0$14.72M2.24%+$14.72M
Dell Technologies Inc.(DELL)13,89932,961+19,062$2.28M$14.22M2.16%+$11.94M
HOLLEY INC4,236,8884,376,888+140,000$13.01M$11.16M1.70%-$1.85M
EYEPOINT INC912,594762,594-150,000$11.76M$10.91M1.66%-$858.2K
SAGIMET BIOSCIENCES INC333,8771,260,544+926,667$1.74M$9.74M1.48%+$8.00M
Corvus Pharmaceuticals, Inc.(CRVS)545,000608,600+63,600$7.97M$9.09M1.38%+$1.12M
ARTIVA BIOTHERAPEUTICS INC0874,542+874,542$0$8.48M1.29%+$8.48M
COMPASS THERAPEUTICS INC2,941,5253,624,076+682,551$15.56M$7.94M1.21%-$7.62M
CONDUENT INC5,036,5955,036,5950$6.45M$7.35M1.12%+$906.6K
Rhythm Pharmaceuticals, Inc.(RYTM)61,45561,4550$5.34M$6.82M1.04%+$1.48M
COMPASS Pathways plc(CMPS)0450,000+450,000$0$6.37M0.97%+$6.37M
Ultragenyx Pharmaceutical Inc.(RARE)302,638182,638-120,000$6.34M$6.10M0.93%-$242.0K
Palvella Therapeutics, Inc.(PVLA)31,25936,259+5,000$3.90M$5.54M0.84%+$1.64M
IMAGENEBIO INC959,337917,692-41,645$4.80M$5.41M0.82%+$617.7K
Viridian Therapeutics, Inc.(VRDN)0260,000+260,000$0$4.78M0.73%+$4.78M
IMMIX BIOPHARMA INC547,552437,552-110,000$4.99M$4.51M0.69%-$477.0K
ORIC Pharmaceuticals, Inc.(ORIC)150,000400,000+250,000$1.90M$4.33M0.66%+$2.43M
LENZ THERAPEUTICS INC506,722756,722+250,000$4.64M$4.30M0.65%-$338.3K
AQUESTIVE THERAPEUTICS INC1,347,932942,932-405,000$5.59M$3.92M0.60%-$1.67M
Starwood Property Trust, Inc.(STWD)158,545196,355+37,810$2.73M$3.22M0.49%+$486.1K
EVOMMUNE INC100,000180,000+80,000$2.30M$2.39M0.36%+$93.2K
ELEDON PHARMACEUTICALS INC1,419,912566,509-853,403$4.37M$2.23M0.34%-$2.14M
CABALETTA BIO INC0714,710+714,710$0$2.22M0.34%+$2.22M
Chime Financial, Inc.(CHYM)089,878+89,878$0$1.84M0.28%+$1.84M
CONTEXT THERAPEUTICS INC5,089,0152,934,015-2,155,000$13.33M$1.63M0.25%-$11.71M
WW INTL INC95,63484,399-11,235$1.31M$1.35M0.20%+$34.7K
MARKER THERAPEUTICS INC554,250554,2500$720.5K$814.7K0.12%+$94.2K
ADC THERAPEUTICS SA733,568733,5680$2.59M$784.9K0.12%-$1.80M
CYBIN INC059,911+59,911$0$396.0K0.06%+$396.0K
FOLD HLDGS INC856,632856,6320$1.13M$385.5K0.06%-$745.3K
NIOCORP DEVS LTD320,100268,280-51,820$525.0K$381.0K0.06%-$144.0K
Rezolve AI PLC(RZLV)235,121235,1210$202.2K$214.0K0.03%+$11.8K
BRAND ENGAGEMENT NETWORK INC1,666,8081,453,808-213,000$416.7K$203.5K0.03%-$213.2K
Piper Sandler Companies(PIPR)2,4282,4280$185.9K$175.6K0.03%-$10.2K
ENGENE THERAPEUTICS INC0511,177+511,177$0$148.2K0.02%+$148.2K
Celcuity Inc.(CELC)01,249+1,249$0$130.7K0.02%+$130.7K
STABLECOINX INC0250,000+250,000$0$102.5K0.02%+$102.5K
Energy Transfer LP(ET)5,3265,3260$102.8K$101.8K0.02%-$959
Caris Life Sciences, Inc.(CAI)4,7114,7110$84.2K$84.0K0.01%-$283
Vodafone Group Public Limited Company(VOD)05,371+5,371$0$71.0K0.01%+$71.0K
Dave Inc.(DAVE)28,75028,7500$7.8K$68.4K0.01%+$60.7K
MURANO GLOBAL INVT PLC
SHS
0261,875+261,875$0$62.9K0.01%+$62.9K
ALPHA MODUS HLDGS INC1,854,6651,854,6650$74.2K$55.6K0.01%-$18.5K
ROADZEN INC225,000225,0000$31.5K$42.8K0.01%+$11.3K
ALPHA MODUS HLDGS INC09,853+9,853$0$42.0K0.01%+$42.0K
AEON BIOPHARMA INC42,35342,3530$41.5K$30.5K0.00%-$11.0K
SOUTHLAND HLDGS INC860,302860,3020$34.4K$25.8K0.00%-$8.6K
BLUE GOLD LTD175,000175,0000$35.0K$21.0K0.00%-$14.0K
SHF HOLDINGS INC75,89775,8970$63.0K$18.2K0.00%-$44.8K
BlackSky Technology Inc.(BKSY)350,000350,0000$14.0K$17.5K0.00%+$3.5K
TEVOGEN BIO HLDGS INC200,000200,0000$6.0K$12.0K0.00%+$6.0K
ZEO ENERGY CORP0250,000+250,000$0$10.0K0.00%+$10.0K
LIVEWIRE GROUP INC0400,000+400,000$0$8.0K0.00%+$8.0K
NVNI GROUP LIMITED
*W EXP 11/01/202
0200,000+200,000$0$6.0K0.00%+$6.0K
KATAPULT HOLDINGS INC5,4215,4210$5.7K$5.4K0.00%-$363
CID HOLDCO INC444,515444,5150$8.9K$4.4K0.00%-$4.4K
BAIRD MED INVT HLDGS LTD
*W EXP 10/01/202
100,000100,0000$9.0K$4.0K0.00%-$5.0K
Pagaya Technologies Ltd.(PGY)48,66148,6610$1.9K$2.4K0.00%+$487
STARDUST PWR INC16,66616,6660$2.7K$2.2K0.00%-$500
LIMINATUS PHARMA INC.50,00050,0000$2.0K$2.0K0.00%$0
WALDENCAST PLC33,33333,3330$1.3K$1.7K0.00%+$334
XBP GLOBAL HOLDINGS INC24,77824,7780$1.5K$1.5K0.00%$0
ASPIRE BIOPHARMA HLDGS INC50,00050,0000$1.0K$1.0K0.00%$0
GOHEALTH INC40,7700-40,770$61.6K$0—-$61.6K
COMPASS Pathways plc(CMPS)904,5040-904,504$5.00M$0—-$5.00M
COMPASS THERAPEUTICS INC400,0000-400,000$500.0K$0—-$500.0K
ENGENE HOLDINGS INC
COM
4,416,3530-4,416,353$30.08M$0—-$30.08M
ENGENE HOLDINGS INC
*W EXP 10/31/202
511,1770-511,177$1.29M$0—-$1.29M
STRUCTURE THERAPEUTICS INC100,0000-100,000$25.0K$0—-$25.0K
KALVISTA PHARMACEUTICALS INC215,0000-215,000$4.33M$0—-$4.33M
LARIMAR THERAPEUTICS INC975,7000-975,700$1.91M$0—-$1.91M
Mineralys Therapeutics, Inc.(MLYS)200,0000-200,000$590.0K$0—-$590.0K
OLEMA PHARMACEUTICALS INC200,0000-200,000$10.0K$0—-$10.0K
OVID THERAPEUTICS INC1,904,6660-1,904,666$4.23M$0—-$4.23M
PLIANT THERAPEUTICS INC2,969,1990-2,969,199$3.74M$0—-$3.74M
Viking Therapeutics, Inc.(VKTX)50,0000-50,000$68.0K$0—-$68.0K
Cardinal Health, Inc.(CAH)1,7180-1,718$363.0K$0—-$363.0K
Enterprise Products Partners L.P.(EPD)31,2900-31,290$1.18M$0—-$1.18M
VODAFONE GROUP PLC5,3710-5,371$80.7K$0—-$80.7K
ALPHA MODUS HLDGS INC394,0780-394,078$145.8K$0—-$145.8K
BITCOIN DEPOT INC50,0000-50,000$1.0K$0—-$1.0K
CID HOLDCO INC557,3610-557,361$94.8K$0—-$94.8K
CIVEO CORP CDA180,4750-180,475$4.78M$0—-$4.78M
KATAPULT HOLDINGS INC400,0000-400,000$0$0—$0
SYNTEC OPTICS HLDGS INC803,1320-803,132$867.4K$0—-$867.4K
Page 1 of 1
Blue Owl Capital Holdings LP — 13F Holdings — Q2 2026 | TickerTrail